Regenxbio (RGNX) EBT Margin Growth (3y) (2017 - 2025)
Regenxbio (RGNX) EBT Margin Growth (3y) (2017 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
49,756.00 |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
441.00 |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
Regenxbio |
325.94 Mn |
95.87 Mn |
- |
-92,443.00 |
| Date | Value |
|---|
| Dec 31, 2025 |
-92,443.00 |
| Sep 30, 2025 |
7,633.00 |
| Jun 30, 2025 |
-12,308.00 |
| Mar 31, 2025 |
35,231.00 |
| Dec 31, 2024 |
-31,879.00 |
| Sep 30, 2024 |
-5,661.00 |
| Jun 30, 2024 |
2,378.00 |
| Mar 31, 2024 |
-14,014.00 |
| Dec 31, 2023 |
-58,873.00 |
| Sep 30, 2023 |
-22,286.00 |
| Jun 30, 2023 |
-15,390.00 |
| Mar 31, 2023 |
-12,147.00 |
| Dec 31, 2022 |
12,026.00 |
| Sep 30, 2022 |
-4,833.00 |
| Jun 30, 2022 |
-18,870.00 |
| Mar 31, 2022 |
330,812.00 |
| Dec 31, 2021 |
6,242.00 |
| Sep 30, 2021 |
19,645.00 |
| Jun 30, 2021 |
-29,766.00 |
| Mar 31, 2021 |
-34,423.00 |
